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Lipid proﬁleAbstract Bile duct ligation (BDL) is a well established experimental model of extrahepatic
cholestasis. Cholestasis leads to progressive liver injury culminating in cirrhosis and liver failure.
Prolonged cholestasis, characterized by retention of bile compound, may cause renal damage, which
sometimes leads to renal failure. The present study aimed to elucidate the curative effect of sepia ink
extract against cholestasis induced renal and lipid metabolism disturbances. Fifty-four male Wistar
albino rats (Rattus norvegicus) were divided into two main groups, the Sham-operated control (18
rats) and bile duct ligated (BDL) group (36 rats). BDL groups were treated orally with sepia ink
extract (200 mg/kg body weight) for 7, 14, and 28 days. The underlying physiological studies were
investigated using lipid proﬁle, kidney function tests and histopathological examination. There was
a signiﬁcant decrease in total lipids, triglycerides, cholesterol and LDL-cholesterol in addition to
kidney function tests; urea, uric acid and creatinine of BDL group after treated with ink extract.
The histopathological examination of the kidney treated with ink extract revealed mild degenera-
tion in renal tissue architecture, as compared to BDL groups. In conclusion, sepia ink extract
provides an antioxidant capacity in vitro and curative strategy against the kidney dysfunctions
induced by BDL.
ª 2014 The Egyptian German Society for Zoology. Production and hosting by Elsevier B.V. All rights
reserved.Introduction
Chronic liver disease is an important cause of morbidity and
mortality and represents a major health problem worldwide(Bessa et al., 2012). Cholestasis is a reduction in bile ﬂow
that leads to the intrahepatic accumulation of bile acids
and other toxic compounds with progression of liver
pathology, including hepatocellular injury and ﬁbrosis
(Crocenzi et al., 2011). The liver plays an essential role in
lipid metabolism, several stages of lipid synthesis and
transportation (Mohammad Reza et al., 2010). Hence, it is
not surprising that liver diseases can affect plasma lipid
levels in a variety of ways (Mandal et al., 2013). Alterations
in lipid metabolism contribute to the pathogenesis and pro-
gression of cholestatic liver disease (Moustafa et al., 2012).
174 A.M. Soliman et al.Cholestasis is associated with hypercholesterolemia as the
major excretory pathway of cholesterol is blocked in this
disorder (Mandal et al., 2013).
The Kidney and the liver are essential organs with multiple
functions. Elimination of numerous potentially toxic xenobiot-
ics, including drugs, toxins, and endogenous metabolites is a
major function of them. Also, it must be mentioned that
impairment of liver or kidney functions can cause injury of
the alternative elimination organ (Torres, 2008). Prolonged
cholestasis, characterized by retention of bile compound,
may cause renal damage which sometimes leads to renal failure
(Torres, 2008). Bile duct ligation (BDL) in rats emerges as a
good model for further studies of hepatorenal syndrome path-
ophysiology and treatment (Assimakopoulos and Vagianos,
2009). Bile duct ligation is characterized by increased systemic
oxidative stress and damage to major organs, including the
liver, brain, heart, intestine, and kidney (Sheen et al., 2010).
Moreover, extrahepatic biliary obstruction usually exhibits
renal damage presenting as higher creatinine levels and ele-
vated tubule interstitial injury scores (Huang et al., 2012). It
was reported that, acute renal failure (ARF) following com-
mon bile duct obstruction remains a major clinical problem
(Wang et al., 2007). Development of ARF in patients with
extrahepatic cholestasis elevated renal vasoconstriction causes
decreases in glomerular ﬁltration rate (GFR) (Scott-Conner
and Grogan, 1994). Also, biliary acids and conjugated biliru-
bin result in tubular necrosis by their ischemic effects and via
direct toxic effects (Green and Better, 1995). Tubular epithelial
injury represents an underestimated but important cause of
renal dysfunction in patients with cholestasis and advanced
liver disease (Fickert et al., 2013). Abnormalities of renal func-
tion are well described in cholestasis (Holt et al., 1999). How-
ever, 10–15% of patients undergoing surgical drainage suffer
signiﬁcant morbidity and mortality due to renal failure
(Cahill et al., 1987; Thompson et al., 1987).
As a consequence of an increasing demand for the biodiver-
sity in screening programs, supplements derived from marine
foods have been used to treat and prevent a wide variety of
lifestyle-related diseases (Fahmy and Hamdi, 2011). Caldwell
(2005) has proposed that the ink of cephalopods contains com-
pounds that are capable of disrupting predator’s chemical
senses. Squid ink is a multifunctional marine bioactive mate-
rial (Sasaki et al., 1997). The problems associated with anti-ﬁb-
rotics are chronic administration, the reduced therapeutic
effects and toxicity, so developing antiﬁbrotics from natural
products may reduce the risk of toxicity and maintain the ther-
apeutic effectiveness when the drug is used clinically (Li and
Friedman, 1999). In addition, data from our previous study
(unpublished data) revealed the anti-ﬁbrotic effect of sepia
ink extract as assessed by decreasing the liver collagen percent-
age using image analysis technique. Therefore, the present
study aimed to elucidate the curative effect of sepia ink extract
against cholestasis induced renal and lipid metabolism distur-
bances in male rats.
Materials and methods
Chemicals and reagents
DPPH (2,2-diphenyl-1-picrylhydrazyl) and ketamine were pur-
chased from Sigma–Aldrich (St. Louis, MO, USA). Kits for allbiochemical parameters were purchased from Bio-diagnostic
Company (Giza, Egypt).
Preparation of cuttleﬁsh sepia ink extract (IE)
Fresh cuttleﬁsh (Sepia ofﬁcinalis) was purchased directly from
a ﬁshmonger and rapidly transferred to the laboratory where
they were dissected. The ink was collected and diluted immedi-
ately with an equal volume of distilled water and mixed
sufﬁciently. The admixture collected immediately, concen-
trated and lyophilized to a black residue using a lyophilizer
(LABCONCO, shell freeze system, USA).
Determination of antioxidant activity (Scavenging Activity
of DPPH Radical)
The free radical scavenging activities of each extract and ascor-
bic acid were analyzed by the DPPH assay (Sa´nchez-Moreno
et al., 1998). A 1.0 ml of the sepia ink extract, at gradient ﬁnal
concentrations of 10, 20, 30, 40, 50, 60, 70 and 80 mg/ml, was
mixed with 2 ml of 0.3 mM DPPH solution in methanol in a
cuvette. The absorbance was taken at 517 nm after 20 min of
incubation in the dark at room temperature. The experiment
was done in triplicates and the percentage antioxidant activity
was calculated as follows
Antioxidant Activity ðAAÞ% ¼ 1 Abssample  Absblank
Abscontrol
  
 100
where:
Abssample was the absorbance of sample solution
(2.0 ml) + DPPH solution (1.0 ml, 0.3 mM),
Absblank was the absorbance of Methanol (1.0 ml) + sam-
ple solution (2.0 ml),
Abscontrol was the absorbance of DPPH solution (1.0 ml,
0.3 mM) + methanol (2.0 ml).
Experimental animals
Male albinoWistar rats (Rattus norvegicus) weighing 150–160 g
were used for the study. The animals were purchased from the
National Research Center (NRC, Giza, Egypt). Rats were
housed under standard conditions and all of the experimental
procedures were approved by the Institutional Animal Care
and Use Committee (IACUC), Faculty of Science, Cairo Uni-
versity, Egypt (CUFS/F/PHY/04/13), in accordance with inter-
national guidelines for the care and use of laboratory animals.
Acute toxicity study (OECD 420)
Male albino rats (Rattus norvegicus) weighing 150–160 ± 5 g
were used for acute toxicity studies. The rats were divided into
control and test groups containing six animals each. The rats
were administered orally with Sepia ofﬁcinalis ink extract
(IE) at dose levels of 5 g/kg (high dose) and 2 g/kg (low dose).
Normal control rats received the same amount of vehicle
(distilled water) only. Rats were observed carefully for 24 h
after extract administration and then for the next 14 days. At
the end of this experimental period, the rats were observed
for signs of toxicity, morphological behavior, and mortality.
Assessment of sepia ink extract 175Acute toxicity was evaluated based on the number of deaths (if
any). Acute toxicity was calculated as per Organization for
Economic Co-operation and Development (OECD) guidelines
420 (Fixed dose method) (Van den Heuvel et al., 1990;
Whitehead and Curnow, 1992).
Bile duct ligation induced liver damage
This protocol was performed according to the method
described by (Vogel and Vogel, 2002). Brieﬂy, rats were
anesthetized with ketamine (Thakare et al., 2009). Laparatomy
was performed under antiseptic conditions. A mid-line incision
in the abdomen was made from the xiphosternum, exposing
the muscle layers and the linea alba, which was then incised
over a length corresponding to the skin incision. The edge of
the liver was then raised and the duodenum pulled down to
expose the common bile duct, which pursues an almost straight
course of about 3 cm from the hilum of the liver to its opening
into the duodenum. There was no gall bladder, and the duct
was embedded for the greater part of its length in the pancreas,
which opens into it by numerous small ducts. A blunt aneu-
rysm needle was passed under the part of the duct selected,
stripping the pancreas away with care, and the duct was
divided between double ligatures of cotton thread. The perito-
neum and the muscle layers as well as the skin wound were
closed with cotton stitches. In sham-operated rats, abdominal
incision was made without a ligation.
Experimental design
Fifty-four male albino rats were assigned into two main
groups, the Sham-operated control (18 rats) and bile duct
ligated (BDL) group (36 rats).
After 14 days, the rats of the Sham-operated group divided
into 3 subgroups (6 rats/subgroup), and animals of these three
subgroups administered distilled water orally for 7, 14, and
28 days.
After 14 days, the rats of the Bile duct ligated (BDL) group
were divided into 6 subgroups (6 rats/subgroup), and animals
of the ﬁrst three subgroups administered distilled water orally
for 7, 14, and 28 days. In the other BDL subgroups, rats were
treated orally with IE (200 mg/kg body weight) for 7, 14, and
28 days.Table 1 Acute toxicity test of Sepia ofﬁcinalis ink extract (IE)
on rats.
Parameter Control IE(5000 mg/
kg, orally)
IE(2000 mg/
kg, orally)
ASAT 123.70 ± 6.01 166.65* ± 3.45 125.70 ± 3.39
ALAT 59.11 ± 0.27 75.90* ± 5.36 63.64 ± 2.85
Values are given as mean ± SE for 5 rats in each group.
* Signiﬁcant at (p< 0.05) as compared with control.Animal handling
At the end of each experimental period (7, 14 and 28 days),
rats were euthanized under chloroform vapor and sacriﬁced
after being fasted overnight. Blood samples were collected in
centrifuge tubes without anticoagulant. The kidney was
removed and immediately blotted using ﬁlter paper to remove
traces of blood and then divided into two parts. The ﬁrst part
stored at 80 C for biochemical analysis. While, the second
part was suspended in 10% buffered formalin for ﬁxation
preparatory to histopathological examination.
Biochemical analysis
The collected blood samples were centrifuged at 3000 rpm for
20 min. The collected serum, stored at 20 C until used forbiochemical assays. Total lipids (Zollner and Kirsch, 1962),
triglycerides (Stein and Myers, 1994), serum total cholesterol
(Richmond, 1973), low density lipoprotein (Wieland and
Seidel, 1983), high density lipoprotein (Lopes-Virella et al.,
1977), creatinine (Tietz and Andresen, 1986), urea, uric acid
and blood urea nitrogen (BUN) (Tietz et al., 1990) were
determined according to the manufacture’s instructions using
Bio-diagnostic kits (Giza, Egypt).
Histological examination
Histological sections (4 lm thick) were prepared from parafﬁn
blocks of hepatic and kidney tissues ﬁxed in 10% formal
saline. Sections were stained with hematoxylin and eosin
(H & E) (Mayer, 1903).
Statistical analysis
Values were expressed as means ± SE. To evaluate differences
between the groups studied, one way analysis of variance
(ANOVA) with Duncan post hoc test was used to compare
the group means and p< 0.05 was considered statistically
signiﬁcant. SPSS, for Windows (version 15.0) was used for
the statistical analysis.
Results
Acute toxicity
In spite of, none of the six rats died after oral administration of
Sepia ofﬁcinalis ink extract (IE) at the higher dose (5000 mg/
kg) in the ﬁrst 24 h or during the experiment (14 days), but,
evidence of toxicity was noticed at the end of the experiment
include increase activities of serum ALAT and serum ASAT
in addition to, alternation in the histopathological examina-
tion of the liver. At the limiting dose (2000 mg/kg) of Sepia
ofﬁcinalis ink extract (IE), there was no mortality and the rats
did not show any sign of toxicity in the ﬁrst 24 h or during the
experiment (Table 1 & Fig. 1). The single lethal dose of (IE)
that kills half of the animals (LD50) was therefore taken as
above 2000 mg/kg. The median effective dose (ED50) was
selected based on the proposed LD50 obtained from the acute
toxicity study. This dose was considered one tenth of the
proposed LD50 (200 mg/kg body weight orally).
Free radical scavenging activity
The radical scavenging activities were estimated by comparing
the percentage of inhibition of DPPH radicals by the tested
A B C 
Figure 1 Photomicrographs of hematoxylin-eosin stained rat liver sections (40X). (A) Control rat. (B) Rat treated with IE (5000 mg/kg).
(C) Rat treated with IE (2000 mg/kg).
176 A.M. Soliman et al.extract and the ascorbic acid. Effect of IE on DPPH free
radical scavenging activity has been done at various concentra-
tions (10, 20, 30, 40, 50, 60, 70 and 80 mg/ml) each in three rep-
lications. The data were displayed with mean ± SEM of three
replications (Table 2). The present results showed that IE has
in vitro antioxidant activity as indicated by dose dependent
inhibition of DPPH radicals ranging from 88.32% to 50.36%.Determination of lipid proﬁle
A signiﬁcant increase (p< 0.05) was observed in the serum
level of total lipids, triglycerides, total cholesterol and LDL-
cholesterol, of BDL rats, after the experimental periods, as
compared to the corresponding Sham groups. While HDL-
cholesterol level decreased after all the experimental periods
(Table 3).
On the other hand, the treatment with IE (200 mg/kg body
weight orally) showed a signiﬁcant decrease (p< 0.05) in the
serum levels of total lipids, triglycerides, total cholesterol and
LDL-cholesterol, of BDL rats after all experimental periods,
as compared to the corresponding sham groups. While the
levels of serum cholesterol and LDL-cholesterol decreased sig-
niﬁcantly (p< 0.05) after 28 days only. On the other hand,
HDL-cholesterol level increases signiﬁcantly (p< 0.05) after
all the experimental periods.
Determination of kidney function tests
Data shown in Table 4 demonstrated that, there are signiﬁcant
decrease (p< 0.05) in serum creatinine, general increase in
serum urea and BUN and signiﬁcant increase (p< 0.05) in
uric acid after the experimental periods, as compared to the
corresponding Sham groups. On the other hand, the treatmentTable 2 Inhibition of DPPH by Sepia ofﬁcinalis ink extract.
Concentration (mg/ml) % inhibition of DPPH by in
10 88.32 ± 2.12
20 75.43 ± 1.22
30 68.32 ± 1.10
40 60.91 ± 1.16
50 59.80 ± 1.15
60 54.31 ± 1.3
70 52.18 ± 1.55
80 50.36 ± 1.34
Values are given as mean ± SE. DPPH: 1,1-Diphenyl-2-picrylhydrazyl.with IE (200 mg/kg body weight orally) showed a general
decrease in serum creatinine, urea, BUN and uric acid after
the experimental periods.Histopathological examination
Microscopic examination of the kidney of Sham groups
showed normal appearance of the tissue where, glomeruli
(G) appear as dense tufts of capillaries enclosed in the outer
layer of Bowman capsules. Numerous renal tubules (r) were
observed (Fig. 2). The kidney of BDL rats showed swelling
and proliferation in the endothelial cells lining the glomerular
tuft of the glomeruli (G) as well as swelling in the epithelial
cells lining the renal tubules (Fig. 2). There were inﬂammatory
cell inﬁltration (I) in between the tubules, degeneration (d) in
the epithelial cells lining the tubules, brush border loss, necro-
sis (N) and deformed renal tissue architecture. On the other
hand, treated groups with IE (200 mg/kg body weight orally)
showed mild degeneration in renal tissue architecture, as
compared to BDL groups (Fig. 2).
Discussion
The liver is the principal site for the formation and clearance of
lipoproteins, it receives fatty acids and cholesterol from
peripheral tissues and diet, packages them into lipoprotein
complexes and releases these complexes back into the circula-
tion (Mandal et al., 2013). Therefore, it is reasonable to expect
an abnormal lipid proﬁle following cholestasis in the present
study. Our results revealed that, total lipid concentration
increased signiﬁcantly in BDL rat’s after all experimental peri-
ods. The present ﬁnding agrees with that of Kinugasa et al.
(1981). The observed hyperlipemia could result from differentk extract % inhibition of DPPH by vitamin C
99.19 ± 0.11
98.48 ± 0.12
99.29 ± 0.34
99.19 ± 0.67
99.59 ± 0.22
98.99 ± 0.56
99.80 ± 0.13
99.39 ± 0.58
Table 4 Curative effect of Sepia ofﬁcinalis ink extract (IE) on kidney Functions of bile duct ligated (BDL) rats.
Parameter Groups Experimental period (days)
7 14 28
Creatinine (mg/dL) Sham 2.95 ± 0.07d 2.93 ± 0.05d 2.95 ± 0.07d
BDL 1.2 ± 0.12a 1.53 ± 0.2a,b 1.2 ± 0.12a
BDL+ Ink 2.13 ± 0.09c 2 ± 0.33b,c 2.13 ± 0.09c
Serum urea (mg/dl) Sham 21.54 ± 1.03a,b 23.33 ± 1.54a,b 21.43 ± 1a,b
BDL 30.31 ± 1.17b 28.7 ± 6.32a,b 31.80 ± 7.06b
BDL+ Ink 25.6 ± 2.88a,b 23 ± 0.12a,b 18.13 ± 0.69a
BUN (mg/dl) Sham 10.06 ± 0.48a 10.90 ± 0.72a 10.01 ± 0.47a
BDL 14.15 ± 0.5a 13.40 ± 2.95a 27.32 ± 4.74b
BDL+ Ink 11.96 ± 1.35a 10.74 ± 0.89a 8.47 ± 0.32a
Serum uric acid (mg/dl) Sham 4 ± 0.09a 3.99 ± 0.07a 3.95 ± 0.08a
BDL 4.29 ± 0.14a 5.9 ± 0.38b 6.84 ± 0.26c
BDL+ Ink 4.18 ± 0.43a 5.89 ± 0.12b 5.18 ± 0.31b
Values are given as mean ± SE for 6 rats in each group.
Each value not sharing a common letter superscript is signiﬁcantly different (p< 0.05).
Table 3 Curative effect of Sepia ofﬁcinalis ink extract (IE) on lipid proﬁle of bile duct ligated (BDL) rats.
Parameter Groups Experimental period (days)
7 14 28
Total lipids (mg/dl) Sham 185.44 ± 9.74a 182.82 ± 9.93a 180.46 ± 10.05a
BDL 327 ± 3.29b 638.28 ± 18.1e 703.31 ± 27.43f
BDL+ Ink 170.7 ± 38.5a 421.66 ± 26.9c 524.08 ± 15.09d
Triglycerides (mg/dl) Sham 87.67 ± 9.31a 85.13 ± 13.88a 81.93 ± 8.67a
BDL 114.31 ± 4.72b 100.91 ± 0.78a,b 112.88 ± 6.03b
BDL+ Ink 99.15 ± 2.29a,b 95.25 ± 6.31a,b 94.745 ± 5.81a,b
Total cholesterol (mg/dl) Sham 51.35 ± 3.12a 51.72 ± 2.99a 51.56 ± 3.08a
BDL 80.56 ± 4.97b 92.62 ± 5.76b,c 103.73 ± 1.89c
BDL+ Ink 89.73 ± 11.33b,c 97.49 ± 6.85b,c 60.97 ± 3.96a
LDL-cholesterol (mg/dl) Sham 153.16 ± 5.03b 151.5 ± 5.79b 150.56 ± 5.52b
BDL 100.76 ± 7.95a 303.85 ± 11.55e 247.33 ± 15.59d
BDL+ Ink 170.69 ± 32.76b,c 207.4 ± 26.17c,d 165.43 ± 10.18b,c
HDL-cholesterol (mg/dl) Sham 44.38 ± 5.57b 44.67 ± 5.69b 44.54 ± 5.59b
BDL 30.99 ± 5.9a,b 44.29 ± 6.47b 19.79 ± 0.81 a
BDL+ Ink 72.44 ± 2.7d 81.39 ± 0.66d 59.08 ± 1.68c
Values are given as mean ± SE for 6 rats in each group.
Each value not sharing a common letter superscript is signiﬁcantly different (p< 0.05).
Assessment of sepia ink extract 177mechanisms, increased plasma free fatty acids (Younes et al.,
1991), hypercholesterolemia (Eder et al., 1955) and/or hyper-
triglyceridemia (Miller et al., 2011). The treatment with IE
caused a signiﬁcant decrease in total lipid concentration of
BDL rats after all the experimental periods. Similarly,
Soliman (2011) reported that, total lipid concentration
decreased in rats after oral administration with fresh water
clams (Coelatura aegyptiaca) extract at doses 100 and
250 mg/kg body weight for 7 days.
Triglycerides and cholesterol, in both free and esteriﬁed
forms, are the two main lipids in plasma (Chapman et al.,
2011). Hepatocyte triglyceride accumulation might incite necr-
oinﬂammatory and ﬁbrotic responses in the liver (Yamaguchi
et al., 2007). Elevated triglycerides are linked with raised con-
centrations of ﬁbrinogen and coagulation factors VII and XII,and with impaired ﬁbrinolysis as determined by enhancing
gene expression and concentrations of plasminogen activator
inhibitor-1 (Grant, 2007). From the present investigation, it
was noticed that serum triglycerideconcentration of BDL rats
increased after all experimental periods. On the other hand, tri-
glyceride concentration decreased in the rats after the treat-
ment with IE. According to Fahmy (in press), triglyceride
concentration decreased signiﬁcantly in the rats after the oral
administration with marine sea cucumber (200 mg/kg body
weight) for 28 days. A reduction in hepatic triglyceride content
might have protected them from liver ﬁbrosis (Yamaguchi
et al., 2007).
Cholesterol is the most abundant neutral lipid in the plasma
membranes of animals and is required for growth (Yeagle,
1985). Homeostasis of cholesterol is centered on the
Figure 2 Photomicrographs of kidney sections under the light microscope. Sham group showing the normal histological structure of the
glomeruli (G), Bowman’s capsule and renal tubules (r). After BDL for three time periods, note brush border loss, degeneration in the
lining epithelial cells in tubules, inﬂammatory cell inﬁltration (I), necrosis (N) and deformed renal tissue architecture. After treatment with
IE (200 mg/kg body weight orally) for three time periods, moderate damage was observed. (H & E, X 400).
178 A.M. Soliman et al.metabolism of lipoproteins, which mediate transport of the
lipid to and from tissues (Daniels et al., 2009). The present
study disclosed that, serum total cholesterol concentration
increases signiﬁcantly in BDL rats after all the experimental
periods. This marked elevation of serum cholesterol that fol-
lows obstruction of the biliary system may be due to an
increase of lipoproteins (Eder et al., 1955). It has been docu-
mented that, the characteristic elevation of cholesterol and
phospholipids in patients with cholestasis is due to the pres-
ence of low density lipoproteins (LDL) of abnormal composi-
tion and properties (Manzato et al., 1976). This lipoprotein is
called ‘‘lipoprotein X’’ (LP-X) (Seidel et al., 1970). Theincrease in LP-X in cholestasis corresponds to the reﬂuxed bile
lipids (Manzato et al., 1976). Thus, hypercholesterolemia is
caused by at least two mechanisms: lipoprotein X formation
and decreased LDL clearance (Flowers et al., 2006). The treat-
ment with IE causes a signiﬁcant decrease in serum total cho-
lesterol concentration in the BDL rats after 28 days only. In
accord with the ﬁnding of Soliman (2011), total cholesterol
concentration decreased in rats after oral administration with
fresh water clams (Coelatura aegyptiaca) at doses 100 and
250 mg/kg body weight for 7 days.
Low density lipoproteins (LDL) are the major cholesterol-
carrying lipoprotein of serum (Expert Panel on Detection,
Assessment of sepia ink extract 1792001). The main function of LDL is to transport cholesterol
from the liver to tissues that incorporate it into cell membranes
(Colpo, 2005). In conjunction with the report of Channa et al.
(2010), the present study indicated that, LDL-cholesterol con-
centration increased signiﬁcantly after bile duct ligation.
Increase in LDL-cholesterol concentration results from an
increase in the production and secretion of LDL that prolongs
its period of circulation (Tiwari, 1999) and decreased LDL
clearance (Flowers et al., 2006). On the other hand, there is
a signiﬁcant decrease in LDL-cholesterol concentration of
BDL rats treated with IE after all the experimental periods.
High density lipoproteins (HDL) are synthesized pre-
dominantly in the liver but also in the intestine (Kanel
et al., 1983). They have two main functions: they are a
substrate for the esteriﬁcation of cholesterol by lecithin cho-
lesterol acyl transferase (LCAT), and they hypothetically
transport excess cholesterol from tissues to the liver
(Sabesin et al., 1979). The present study disclosed that,
HDL-cholesterol concentration decreased generally after all
the experimental periods. A reduction in plasma lecithin
cholesterol acyl transferase (LCAT) activity may also
potentially explain the decrease in HDL (Zhu et al., 2004;
Flowers et al., 2006). The treatment with IE causes a signif-
icant increase in HDL level after all the experimental peri-
ods. Soliman (2011) demonstrated that, HDL-cholesterol
concentration increased in rats after oral administration
with fresh water clams (Coelatura aegyptiaca) at doses
100 and 250 mg/kg body weight for 7 days.
Hyperbilirubinemia has been shown to potentially affect
renal function (Ozturk et al., 2010). These are associated with
a urinary concentration defect, decreased maximal free water
clearance and increased fractional sodium excretion (Call
and Tisher, 1975), leading to signiﬁcant changes in renal func-
tion and damage to the renal epithelium (Padillo et al., 2005).
In addition, a predominant observation is reversible renal
vasoconstriction that can lead to hepatorenal syndrome and
renal failure (Ozturk et al., 2010).
Creatinine is an endogenous substance produced by muscle
from creatine and creatine phosphate, with a rate of produc-
tion proportionate to the muscle mass (Kurniawan et al.,
2013). The measurement of serum creatinine proves useful test
in diagnosing renal failure and diseases where, directly propor-
tional relationship exists between creatinine levels and renal
function (Sharma, 2011). Our results disclosed that, serum cre-
atinine increased signiﬁcantly in BDL rats after all the experi-
mental periods. This increase in serum creatinine may be due
to the hepatic damage which evolved into a stage with features
of hepatorenal syndrome (Arroyo and Jimenez, 2000) includ-
ing reduction in creatinine clearance and low glomerular ﬁltra-
tion rate (Briglia and Anania, 2002). On the other hand, an
oral administration with IE caused a signiﬁcant decrease in
serum creatinine concentration in BDL rats after all the exper-
imental periods which conﬁrmed to some extent by the kidney
histopathological examination. According to Fahmy et al.
(2009), serum creatinine decreased in the treated rats after oral
administration with marine crustacean Erugosquilla massaven-
sis extract at doses 50, 100 and 250 mg/kg body weight for
9 days.
Urea is the major nitrogenous end product of protein and
amino acid catabolism, produced by the liver and distributed
throughout intracellular and extracellular ﬂuid. The most
frequently determined clinical indices for estimating renalfunction depend upon the concentration of urea in the serum
(Gowda et al., 2010). Hepatorenal syndrome is most frequently
ﬁrst diagnosed by a ﬁnding of increasing concentrations of
serum creatinine or blood urea nitrogen (BUN) (Gine`s et al.,
2003). The present study revealed that, serum urea and blood
urea nitrogen increased generally after all the experimental
periods. These results were in conjugation with that of
Akcay et al. (2010). On the other hand, the treatment with
IE caused a general decrease in serum urea and blood urea
nitrogen after all the experimental periods. Similarly, Fahmy
et al. (2009) indicated that, serum urea and BUN decreased
in the treated rats after oral administration with freshwater
crustacean Procombarus clarkii at doses 100 and 250 mg/kg
body weight for 9 days.
Uric acid is formed by the liver and mainly excreted by
the kidneys (65–75%) and intestines (25–35%) (de Oliveira
and Burini, 2012). The present study revealed that serum
uric acid concentration increased signiﬁcantly in BDL rats
after the experimental periods. The present ﬁnding agrees
with that of Xie et al. (2013). Increased triglyceride synthesis
in individuals with metabolic abnormalities would also accel-
erate serum uric acid production and accumulation (Choi
and Diehl, 2008). In addition, inﬂammatory factors which
induced oxidative stress and apoptosis have been suggested
to be important factors for more serious liver damage,
resulting in uric acid production (Xie et al., 2013). IE treat-
ment causes a general decrease in serum uric acid concentra-
tion of the BDL rats after all the experimental periods.
According to Fahmy et al. (2009), serum uric acid decreased
in the treated rats after oral administration with marine
crustacean Erugosquilla massavensis extract at doses (100
and 250 mg/kg body weight) for 9 days.
In conclusion, the results of the present study indicated
that, oral administration of sepia ink extract at the tested dose
attenuates kidney functions associated with extrahepatic chole-
stasis induced by bile duct ligation through improving renal
function tests. In addition, our results revealed the presence
of considerable amounts of antioxidants in sepia ink extract,
which provides an evidence for the curative effect and antiox-
idant capacity, as revealed by signiﬁcant reduction of urea,
uric acid and creatinine of BDL-rats treated with sepia ink
extract in comparison with untreated BDL groups throughout
all the experiment periods.
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